X-111152384-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002578.5(PAK3):​c.431-26A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0453 in 1,093,025 control chromosomes in the GnomAD database, including 5,383 homozygotes. There are 13,518 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.16 ( 2785 hom., 4678 hem., cov: 23)
Exomes 𝑓: 0.033 ( 2598 hom. 8840 hem. )

Consequence

PAK3
NM_002578.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.771

Publications

3 publications found
Variant links:
Genes affected
PAK3 (HGNC:8592): (p21 (RAC1) activated kinase 3) The protein encoded by this gene is a serine-threonine kinase and forms an activated complex with GTP-bound RAS-like (P21), CDC2 and RAC1. This protein may be necessary for dendritic development and for the rapid cytoskeletal reorganization in dendritic spines associated with synaptic plasticity. Defects in this gene are the cause of a non-syndromic form of X-linked intellectual disability. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2017]
PAK3 Gene-Disease associations (from GenCC):
  • corpus callosum, agenesis of
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • intellectual disability, X-linked 30
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • X-linked syndromic intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant X-111152384-A-G is Benign according to our data. Variant chrX-111152384-A-G is described in ClinVar as Benign. ClinVar VariationId is 1231786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.484 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002578.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PAK3
NM_002578.5
MANE Select
c.431-26A>G
intron
N/ANP_002569.1
PAK3
NM_001128168.3
c.539-26A>G
intron
N/ANP_001121640.1
PAK3
NM_001128172.2
c.494-26A>G
intron
N/ANP_001121644.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PAK3
ENST00000372007.10
TSL:1 MANE Select
c.431-26A>G
intron
N/AENSP00000361077.4
PAK3
ENST00000360648.8
TSL:1
c.539-26A>G
intron
N/AENSP00000353864.4
PAK3
ENST00000417227.5
TSL:1
c.494-26A>G
intron
N/AENSP00000389172.1

Frequencies

GnomAD3 genomes
AF:
0.155
AC:
17206
AN:
111012
Hom.:
2784
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.490
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0709
Gnomad ASJ
AF:
0.0299
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0328
Gnomad FIN
AF:
0.0104
Gnomad MID
AF:
0.0591
Gnomad NFE
AF:
0.0228
Gnomad OTH
AF:
0.125
GnomAD2 exomes
AF:
0.0579
AC:
10484
AN:
181087
AF XY:
0.0457
show subpopulations
Gnomad AFR exome
AF:
0.503
Gnomad AMR exome
AF:
0.0310
Gnomad ASJ exome
AF:
0.0329
Gnomad EAS exome
AF:
0.000218
Gnomad FIN exome
AF:
0.0134
Gnomad NFE exome
AF:
0.0212
Gnomad OTH exome
AF:
0.0353
GnomAD4 exome
AF:
0.0329
AC:
32302
AN:
981962
Hom.:
2598
Cov.:
18
AF XY:
0.0302
AC XY:
8840
AN XY:
292790
show subpopulations
African (AFR)
AF:
0.497
AC:
11484
AN:
23099
American (AMR)
AF:
0.0365
AC:
1274
AN:
34903
Ashkenazi Jewish (ASJ)
AF:
0.0312
AC:
579
AN:
18533
East Asian (EAS)
AF:
0.0000338
AC:
1
AN:
29553
South Asian (SAS)
AF:
0.0402
AC:
2062
AN:
51335
European-Finnish (FIN)
AF:
0.0145
AC:
582
AN:
40276
Middle Eastern (MID)
AF:
0.0731
AC:
283
AN:
3869
European-Non Finnish (NFE)
AF:
0.0187
AC:
13769
AN:
738199
Other (OTH)
AF:
0.0538
AC:
2268
AN:
42195
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
768
1537
2305
3074
3842
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
652
1304
1956
2608
3260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.155
AC:
17232
AN:
111063
Hom.:
2785
Cov.:
23
AF XY:
0.140
AC XY:
4678
AN XY:
33311
show subpopulations
African (AFR)
AF:
0.490
AC:
14862
AN:
30324
American (AMR)
AF:
0.0708
AC:
739
AN:
10443
Ashkenazi Jewish (ASJ)
AF:
0.0299
AC:
79
AN:
2639
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3561
South Asian (SAS)
AF:
0.0314
AC:
83
AN:
2646
European-Finnish (FIN)
AF:
0.0104
AC:
63
AN:
6042
Middle Eastern (MID)
AF:
0.0602
AC:
13
AN:
216
European-Non Finnish (NFE)
AF:
0.0228
AC:
1206
AN:
52984
Other (OTH)
AF:
0.123
AC:
187
AN:
1521
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
353
706
1059
1412
1765
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
156
312
468
624
780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0420
Hom.:
362
Bravo
AF:
0.177

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Intellectual disability, X-linked 30 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.42
DANN
Benign
0.35
PhyloP100
-0.77
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16986385; hg19: chrX-110395612; API